A Hallucinogenic Tea, Laced with Controversy: AYAHUASCA IN THE AMAZON AND THE UNITED STATES

A Hallucinogenic Tea, Laced with Controversy: Ayahuasca in the Amazon and the United States

Volumn , Issue , 2008, Pages 1-163

  de Rios, Marlene Dobkin ^a   Rumrrill, Roger ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b NONE   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85183269771     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (64)

1. Adelaars, A. (1997). Psychedelic rituals in the Netherlands. In: C. Ratsch & J. Baker (Eds.), Yearbook for ethnomedicine and the study of consciousness, 6–78. Berlin, Germany: Verlag fur Wissenschaft und Bildung.
2. Baker, J. (2005). Psychedelic sacraments. Journal of Psychoactive Drugs, 37(2), 179–188.
3. Barbosa, P.C., Giglio, J.S., Dalgalarrondo, P. (2005). Altered states of consciousness andshort term psychological after-effects induced by first-time ritual use of ayahuascain an urban center in Brazil. Journal of Psychoactive Drugs, 37(2), 193–202.
4. Berg, A.A. (2003). Deconstructing travel: Cultural perspectives on tourism. WalnutCreek, CA: Altamira Press.
5. Bianchi, A., & Samorini, G. (1997). Plants in association with ayahuasca. In: C. Ratsch & J. Baker (Eds.), Yearbook for ethnomedicine and the study of consciousness. Berlin, Germany: Verlag fur Wissenschaft und Bildung.
6. Brannigin, W. (2006). Court allows for use of hallucinogenic tea. Retrieved February 21, 2008, from http://www.maps.org/sys/nq.pl?id=787&fmt=page.
7. Bruner, E.M. (2006). Culture on tour: Ethnographies of travel. Chicago: University ofChicago Press.
8. Calabrese, J.D. (2001). The Supreme Court versus peyote: Consciousness alteration, cultural psychiatry and the dilemma of contemporary subcultures. Anthropologyof Consciousness, 12(2), 4–19.
9. Callaway, J.C., Airaksinen, M.M., McKenna, D., Glacus, B., & Grob, C. (1994).Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology,116, 385–387.
10. Catholic Encyclopedia. (2003). Volume V11. Online edition. John Cardinal Farley. Archbishop of New York. Retrieved October 27, 2006, from http://www.newadvent.org.
11. Coppens, W., & David-Cato, J. (1971). El yopo entre los Cuiva-Guahibo: Aspectosetnográficos y farmacológicos. Antropologica, 28, 3–24.
12. Cushman, P. (1990). Why the self is empty: Toward a historically situated psychology. American Psychology, 45(5), 599–611.
13. Dobkin de Rios, M. (1969). Curanderismo psicode´lico en el Peru. Continuidad ycambio. Mesa redonda de ciencias prehistó ricas y antropológicas. Lima:Catholic University of Peru.
14. Doblin, R. (2006). MAPS 20th Anniversary Financial Report, xvi(30), 2–12.
15. Durkheim, E. (1951). The elementary forms of the religious life. New York: CollierBooks. (Original work published 1932)
16. Eysenck, H.J. (1975). Encyclopedia of psychology. Vol. 2. (pp. 1–12). Bungay. New Guinea.
17. Feeney, K. (2007). The legal bases for religious peyote use. In: M. J. Winkelman &T.B. Roberts (Eds.), Psychedelic medicine (pp. 233–250).Westport, CT: Praeger.
18. Frecska, E. (2007). Dangers and contraindications in therapeutic applications ofhallucinogens. In: M.J. Winkelman & T.B. Roberts (Eds.), Psychedelic medicine(pp. 69–96). Westport, CT: Praeger.
19. Freud, S. (1989). The future of an illusion. S. James, Ed. New York: Doubleday.
20. Friedman, T.L. (2000). The Lexus and the olive tree. New York: Anchor Books.
21. Gehricke, J.G., et al. (2007). Smoking to self-medicate attentional and emotional dysfunctions. Nicotine & Tobacco Research, 9, 523–536.
22. Grob, C.S. (2007). The use of psilocybin in patients with advanced cancer and existentialanxiety. In; M. J. Winkelman & T.B. Roberts (Eds.), Psychedelic medicine (pp. 205–216). Westport, CT: Praeger.
23. Grob, C.S. & Dobkin de Rios, M. (1992). Adolescent drug use in cross-cultural perspective. Journal of Drug Issues, 22(1), 121–138.
24. Grob, C. S., McKenna, D., Callaway, J., Brito, G.S., Neves, G., & Oberlander, O. (1994.) Human psychopharmacology of hoasca, a plant hallucinogen usedin ritual context in Brazil. Journal of Nervous and Mental Disease, 184(2), 86–94.
25. Groisman, A. (1999). Transplanting contexts: Cultural frontiers and transcultural knowledge in the expansion of ayahuasca cults to Europe. Unpublished manuscript.
26. Groisman, A., & Dobkin de Rios, M. (2007). Ayahuasca, the U.S. Supreme Court, and the UDV-U.S. government case: Culture, religion, and implications of alegal dispute. In: M.J. Winkelman & T.B. Roberts (Eds.), Psychedelic medicine. Westport, CT: Praeger.
27. Halpern, J.H., & Pope, H.G. (2001). Hallucinogens on the Internet: A vast new source of underground drug information. American Journal of Psychiatry,158(3), 481–483.
28. Heelas, P. (1996). The New Age movement. The celebration of the self and The sacralisation of modernity. London: Blackwell.
29. Krippner, S. (1999). Close encounters of the shamanic kind: From meetings to models. In: A. Schenk & C. Ratsch (Eds.), What is a shaman? Berlin, Germany: Verlag fur Wissenschaft und Bildung.
30. Lathrap, D. (1979). The upper Amazon. New York: Thames and Hudson.
31. Lucas, M. (2005). On not passing the acid test: Bad trips and initiation. Anthropologyof Consciousness, 16(1), 25–27.
32. Luna, E. (1984). The concept of plants as teachers among four mestizo shamans ofIquitos, northeastern Peru. Journal of Ethnopharmacology, 111(2), 135–156.
33. Mabit, J. (2002). Blending traditions: Using indigenous medicinal knowledge totreat drug addiction. MAPS Bulletin, 12(2), 25–32.
34. Mabit, J., & Sieber, C. (2006). The evolution of a pilot program utilizing ayahuasca in the treatment of drug addictions. Shaman’s Drum.
35. MacCrae, E. (1999). The ritual and religious use of ayahuasca in contemporary Brazil. DPF XII Policy Manual (pp. 47–50). W. Taylor, W. Stewart, R. Hopkins,& K. Ehlers, Eds. Washington DC: The Drug Policy Foundation.
36. Masters, R., & Houston, J. (1966). The varieties of psychedelic experience. New York: Delta Publishing.
37. Montagne, M. (2007). Psychedelic therapy for treatment of depression. In: M. J. Winkelman & T.B. Roberts (Eds.), Psychedelic medicine. Westport, CT: Praeger.
38. Moreno, F., & Delgado, P.L. (2007). Psilocybin treatment of obsessive compulsivedisorder. In: M.J. Winkelman & T.B. Roberts (Eds.), Psychedelic medicine. Westport, CT: Praeger.
39. Ortegay Gasset, J. (1992). The revolt of the masses. New York: W.W. Norton & Co.(Original work published 1932)
40. Owen-Kostelnik, J., Reppucci, N., & Meyer, J.R. (2006). Testimony and interrogation of minors. American Psychologist, 61(4), 286–304.
41. Reko, V.A. (1949). Magische gifte: rausch-und betaubungsmittle der neuen welt (pp. 65–76). Stuttgart, Germany: Ferdinand Enke Verlag.
42. Riba, J., et al. (2004). Effects of South American psychoactive beverage ayahuasca onregional brain electrical activity in humans: A functional neuro-imaging studyusing low-resolution electromagnetic tomography. Neuropsychology, 50, 89–101.
43. Rivier, L., & Lindgren, J. (1972). Ayahuasca, the South American hallucinogenicdrink: An ethno-botanical and chemical investigation. Journal of Economic Botany, 23(1), 101–29.
44. Rodd, R. (2006). Piaroa sorcery and the navigation of negative affect: To be aware, toturn away. Anthropology of Consciousness, 17(1), 35–64.
45. Santo Daime. (2007). Alternative religions’ profiles. Retrieved September 21, 2007, from http://www.santodaime.org.
46. Seguin, C.A. (1974). Folklore psychiatry. Lima, Peru: Ediciones Edmar.
47. Seligman, M. (2002). Learned optimism: How to change your mind and your life. New York: Free Press.
48. Siegel, R.K. (1989). Intoxication: Life in pursuit of artificial paradise. New York:Simon and Schuster.
49. Simon, H.A. (1990). A mechanism for social selection and successful altruism. Science, 250, 1665–1668.
50. Siskind, J. (1973). Visions and cures among the Sharanahua. In: M.J. Harner (Ed.), Hallucinogens and shamanism (pp. 28–39). New York: Oxford University Press.
51. Sjoberg, B.M., & Hollister, E. (1965). The effects of psychotomimetic drugs on primary suggestibility. Psychopharmacologia (Berlin), 8, 251–262.
52. Skinner, B.F. (1971). Beyond freedom and dignity. New York: A. Knopf.
53. Sklerov J.B., Levine, K., More, A., King, T., & Fowler, D. (2005). A fatal intoxication following the ingestion of 5-methoxy-N, N-dimethyltryptamine in anayahuasca preparation. Journal of Analytical Toxicology, 29, 838–841.
54. Smith, H. (2005). Do drugs have religious import? A forty year follow-up. In: R. Walsh & C.S. Grob (Eds.), Higher wisdom: Eminent elders explore the continuing impact of psychedelics. Albany, NY: State University of New York Press.
55. Stephens, R. S. (1999). Cannabis and hallucinogens. In: B. S. McCrady &E. E. Epstein (Eds.), Addictions: A comprehensive guidebook (pp. 121–140).New York: Oxford University Press.
56. Tart, C.S. (1969). Altered state of consciousness. New York: John Wiley and Sons.
57. Tournon, J. (2002). La merma magica. Vida e historia de los Shipibo-Conibo delUcayali. Lima, Peru: CAAAP (Centro Amazonico de Antropologia y AplicacionPractica).
58. Tupper, K.W. (2006). The globalization of ayahuasca: Harm reduction or benefitmaximization? International Journal of Drug Policy.
59. Tupper, K.W. (n.d.). Ayahuasca healing beyond the Amazon: The globalization of atraditional indigenous entheogenic practice. Unpublished manuscript.
60. Uniao do Vegetal [UDV]. (2007). Retrieved March 6, 2007, from http://www.udv.org.br/and http://www.udvusa.com/.
61. Wasson, R.G., et al. (1998). The road to Eleusis: Unveiling the secret of the mysteries. Los Angeles, CA: Hermes Press.
62. Winkelman, M. (2000). Shamanism: The neural ecology of consciousness and healing. Westport, CT: Bergin and Garvey.
63. Winkelman, M. (2005). Drug tourism or spiritual healing? Ayahuasca seekers in: Amazonia. Journal of Psychoactive Drugs, 37(2), 209–218.
64. York, M. (2001). New Age commodification and appropriation of spirituality. Journal of Contemporary Religion, 16(3), 361–372.